Xeris Biopharma Holdings, Inc.

VOLORIDGE INVESTMENT MANAGEMENT, LLC XERS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

811,129

Value ($000)

6,367

Weight

0.0%

2025 Q1 - 2025 Q4 (4 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	6,367	0.0%	811,129	12/31/2025
2025 Q3	11/14/2025	8,421	0.0%	1,034,553	9/30/2025
2025 Q2	8/14/2025	4,644	0.0%	994,381	6/30/2025
2025 Q1	5/15/2025	7,418	0.0%	1,351,114	3/31/2025